載入...
Mechanisms of Action of the New Antibodies in Use in Multiple Myeloma
Monoclonal antibodies (mAbs) directed against antigen-specific of multiple myeloma (MM) cells have Fc-dependent immune effector mechanisms, such as complement-dependent cytotoxicity (CDC), antibody-dependent cellular cytotoxicity (ADCC), and antibody-dependent cellular phagocytosis (ADCP), but the c...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8297441/ https://ncbi.nlm.nih.gov/pubmed/34307150 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.684561 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|